CARDIOVASCULAR EVENT RATES IN A HIGH-RISK MANAGED CARE POPULATION IN THE UNITED STATES

Healthcare policy for reducing cardiovascular (CV) event burden should be guided by current and generalizable data. The objective was to determine the CV event risk in US patients with established atherosclerotic CV disease (ASCVD) and/or diabetes mellitus. The MarketScan Research Database was used